343 results on '"Ficker Joachim H"'
Search Results
2. Older patients with EGFR mutation-positive non-small cell lung cancer treated with afatinib in clinical practice: A subset analysis of the non-interventional GIDEON study
3. Ruxolitinib in addition to standard of care for the treatment of patients admitted to hospital with COVID-19 (RUXCOVID): a randomised, double-blind, placebo-controlled, phase 3 trial
4. Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial
5. Positive airway pressure telehealth models and long-term therapy termination: a healthcare database analysis
6. Prävalenz und Prädiktoren der positiven Atemwegsdrucktherapie bei obstruktiver Schlafapnoe: eine bevölkerungsrepräsentative Studie
7. CAT score single item analysis in patients with COPD: Results from COSYCONET
8. Wenn CPAP nicht genutzt oder nicht vertragen wird – Vorschlag für eine standardisierte Terminologie
9. Fluctuation of Acquired Resistance Mutations and Re-Challenge with EGFR TKI in Metastatic NSCLC: A Case Report
10. Assessment of clinical outcome after endoscopic lung volume reduction with one-way valves in emphysema patients and a very-low 6 minute walk test at baseline
11. Bronchoscopic Thermal Vapor Ablation (BTVA) in patients with severe upper lobe predominant emphysema: 36 months follow-up results from a prospective registry
12. Erektionsstörungen und nächtliche penile Tumeszenz (NPT)
13. Compatibility of medication with PRISCUS criteria and identification of drug interactions in a large cohort of patients with COPD
14. Effect of a patient engagement tool on positive airway pressure adherence: analysis of a German healthcare provider database
15. Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)
16. Role of dual bronchodilators in COPD: A review of the current evidence for indacaterol/glycopyrronium
17. Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)
18. German S3 Guideline Nonrestorative Sleep/Sleep Disorders, chapter “Sleep-Related Breathing Disorders in Adults,” short version: German Sleep Society (Deutsche Gesellschaft für Schlafforschung und Schlafmedizin, DGSM)
19. Trends der Lungenkrebsinzidenz nach histologischem Subtyp bei Männern und Frauen in Deutschland: Analyse von Krebsregisterdaten unter Einsatz von multipler Imputation
20. Segmental volume reduction using thermal vapour ablation in patients with severe emphysema: 6-month results of the multicentre, parallel-group, open-label, randomised controlled STEP-UP trial
21. Response of an HER2-Mutated NSCLC Patient to Trastuzumab Deruxtecan and Monitoring of Plasma ctDNA Levels by Liquid Biopsy
22. Predictors of positive airway pressure therapy termination in the first year: analysis of big data from a German homecare provider
23. Reduced decline of lung diffusing capacity in COPD patients with diabetes and metformin treatment
24. Telemedicine-based proactive patient management during positive airway pressure therapy: Impact on therapy termination rate
25. Older patients with EGFR mutation-positive non-small cell lung cancer treated with afatinib in clinical practice: A subset analysis of the non-interventional GIDEON study
26. Erlotinib treatment after platinum-based therapy in elderly patients with non-small-cell lung cancer in routine clinical practice – results from the ElderTac study
27. Detection of cardiovascular risk from a photoplethysmographic signal using a matching pursuit algorithm
28. Disease Progression and Age as Factors Underlying Multimorbidity in Patients with COPD: Results from COSYCONET
29. Isavuconazole therapeutic drug monitoring in critically ill ICU patients: A monocentric retrospective analysis
30. Disease Progression and Age as Factors Underlying Multimorbidity in Patients with COPD: Results from COSYCONET
31. Specialized Biopsychosocial Care in Inpatient Somatic Medicine Units—A Pilot Study
32. Zytostatische oder zielgerichtete antineoplastische Medikamente
33. Spontanpneumothorax
34. Associations of oxygenated hemoglobin with disease burden and prognosis in stable COPD: Results from COSYCONET
35. Lower Prevalence of Osteoporosis in Patients with COPD Taking Anti-Inflammatory Compounds for the Treatment of Diabetes: Results from COSYCONET
36. Erratum to: German S3 Guideline Nonrestorative Sleep/Sleep Disorders, chapter “Sleep-Related Breathing Disorders in Adults,” short version: German Sleep Society (Deutsche Gesellschaft für Schlafforschung und Schlafmedizin, DGSM)
37. Efficacy of docetaxel plus ramucirumab as palliative second-line therapy following first-line chemotherapy plus immune-checkpoint-inhibitor combination treatment in patients with non-small cell lung cancer (NSCLC) UICC stage IV
38. Beyond the AHI–pulse wave analysis during sleep for recognition of cardiovascular risk in sleep apnea patients
39. sj-pdf-1-tam-10.1177_17588359211012361 – Supplemental material for Afatinib as first-line treatment in patients with EGFR-mutated non-small cell lung cancer in routine clinical practice
40. Predictive value of mRNA expression and dynamic changes from immune related biomarkers in liquid biopsies before and after start of pembrolizumab in stage IV non-small cell lung cancer (NSCLC)
41. Lower Prevalence of Osteoporosis in Patients with COPD Taking Anti-Inflammatory Compounds for the Treatment of Diabetes: Results from COSYCONET
42. Bridging Whole-Lung Lavage with Venovenous Extracorporeal Life Support for Pulmonary Alveolar Proteinosis
43. Refraktäre Dyspnoe bei fortgeschrittener COPD: Palliative Therapie mit Opioiden
44. Checkpointinhibitor assoziierte Pneumonitiden
45. Glycopyrronium and Tiotropium Demonstrate Similar Improvements in Lung Function and Reductions in Exacerbations in Severe-To-Very Severe COPD: The SPARK Study: OS215
46. Neue Methoden der nasalen Überdrucktherapie bei der Schlafapnoe
47. Relationship between clinical and radiological signs of bronchiectasis in COPD patients: Results from COSYCONET
48. an international multicentre single-arm clinical trial
49. Predictive value of mRNA expression and dynamic changes from immune related biomarkers in liquid biopsies before and after start of pembrolizumab in stage IV non-small cell lung cancer (NSCLC)
50. Afatinib as first-line treatment in patients with EGFR-mutated non-small cell lung cancer in routine clinical practice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.